Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06040476 | NOT YET RECRUITING | Acute Ischemic Stroke

Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke (AIS)
Sponsor:

StemCyte, Inc.

Brief Summary:

A Phase II, Randomized, Double-blind, Parallel, Placebo-controlled Study to Assess the Safety and Efficacy of Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke

Condition or disease

Acute Ischemic Stroke

Intervention/treatment

hUCB

Phase

PHASE2

Detailed Description:

This is a phase II study to evaluate the safety and efficacy in hUCB treatment on the patients with acute ischemic stroke (AIS).

Study Type : INTERVENTIONAL
Estimated Enrollment : 39 participants
Masking : DOUBLE
Primary Purpose : TREATMENT
Official Title : A Phase II, Randomized, Double-blind, Parallel, Placebo-controlled Study to Assess the Safety and Efficacy of Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke
Actual Study Start Date : 2025-09
Estimated Primary Completion Date : 2027-12
Estimated Study Completion Date : 2028-08

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years to 80 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Male or female subject ≥18 and ≤80 years of age.
  • * Subject with a confirmed diagnosis of AIS and hemiplegia
Exclusion Criteria
  • * Subject with known immune disease, immunodeficiency, or receives immunosuppressive therapy/immunomodulators within 4 weeks or 5 half-lives prior to screening, whichever is longer.
Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke (AIS)

Location Details

NCT06040476

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

No Location Found